[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100604803":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":28,"centralContacts":33,"locations":39,"responsibleParty":231,"collaborators":27,"id":233,"slug":234,"hasResults":235,"nctId":236,"briefTitle":237,"officialTitle":238,"acronym":27,"eligibilityCriteria":239,"healthyVolunteers":235,"sex":240,"minAge":241,"maxAge":27,"enrollmentInfo":242,"targetDuration":27,"studyType":245,"phases":246,"briefSummary":248,"conditions":249,"keywords":27,"overallStatus":42,"whyStopped":27,"lastUpdateSubmitDate":251,"lastUpdatePostDateStruct":252,"startDateStruct":255,"completionDateStruct":257,"leadSponsor":259,"locationsCount":260},{"fullName":5,"class":6},"Dizal Pharmaceuticals","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Combination of DZD8586 and Venetoclax","EXPERIMENTAL","DZD8586 will be taken orally once daily on days 1-28 of each cycle. Venetoclax will be taken orally once daily on days 1-28 starting from cycle 4 day 1.",[13,14],"Drug: DZD8586","Drug: Venetoclax",[16,23],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"DRUG","DZD8586","DZD8586 will be taken orally once daily on days 1-28 of each cycle.",[9],[22],"Birelentinib",{"type":17,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"Venetoclax","Venetoclax will be taken orally once daily on days 1-28 starting from cycle 4 day 1.",[9],null,[29],{"name":30,"affiliation":31,"role":32},"Niu","West China Hospital","PRINCIPAL_INVESTIGATOR",[34],{"name":35,"role":36,"phone":37,"phoneExt":27,"email":38},"Ling Zhou","CONTACT","0086-21-61095755","ling.zhou@dizalpharma.com",[40,57,70,83,92,105,118,130,142,155,167,179,192,206,218],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Anhui Provincial Cancer Hospital","RECRUITING","Hefei","Anhui","230031","China","CN",{"type":49,"coordinates":50},"Point",[51,52],117.28083,31.86389,{"lat":52,"lon":51},[55],{"name":56,"role":36,"phone":27,"phoneExt":27,"email":27},"Ding",{"facility":58,"status":42,"city":59,"state":60,"zip":61,"country":46,"countryCode":47,"cosmosGeoPoint":62,"geoPoint":66,"contacts":67},"Peking University Third Hospital","Beijing","Beijing Municipality","100191",{"type":49,"coordinates":63},[64,65],116.39723,39.9075,{"lat":65,"lon":64},[68],{"name":69,"role":36,"phone":27,"phoneExt":27,"email":27},"Jing",{"facility":71,"status":42,"city":72,"state":73,"zip":74,"country":46,"countryCode":47,"cosmosGeoPoint":75,"geoPoint":79,"contacts":80},"Zhujiang Hospital of Southern Medical University","Guangzhou","Guangdong","510280",{"type":49,"coordinates":76},[77,78],113.25,23.11667,{"lat":78,"lon":77},[81],{"name":82,"role":36,"phone":27,"phoneExt":27,"email":27},"Li",{"facility":84,"status":42,"city":72,"state":73,"zip":85,"country":46,"countryCode":47,"cosmosGeoPoint":86,"geoPoint":88,"contacts":89},"Nanfang Hospital, Southern Medical University","510515",{"type":49,"coordinates":87},[77,78],{"lat":78,"lon":77},[90],{"name":91,"role":36,"phone":27,"phoneExt":27,"email":27},"Guo",{"facility":93,"status":42,"city":94,"state":95,"zip":96,"country":46,"countryCode":47,"cosmosGeoPoint":97,"geoPoint":101,"contacts":102},"Henan Cancer Hospital","Zhengzhou","Henan","450008",{"type":49,"coordinates":98},[99,100],113.64861,34.75778,{"lat":100,"lon":99},[103],{"name":104,"role":36,"phone":27,"phoneExt":27,"email":27},"Zhou",{"facility":106,"status":42,"city":107,"state":108,"zip":109,"country":46,"countryCode":47,"cosmosGeoPoint":110,"geoPoint":114,"contacts":115},"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","Wuhan","Hubei","430022",{"type":49,"coordinates":111},[112,113],114.26667,30.58333,{"lat":113,"lon":112},[116],{"name":117,"role":36,"phone":27,"phoneExt":27,"email":27},"Fang",{"facility":119,"status":42,"city":120,"state":108,"zip":121,"country":46,"countryCode":47,"cosmosGeoPoint":122,"geoPoint":126,"contacts":127},"Yichang Central People's Hospital","Yichang","443003",{"type":49,"coordinates":123},[124,125],111.28472,30.71444,{"lat":125,"lon":124},[128],{"name":129,"role":36,"phone":27,"phoneExt":27,"email":27},"Cai",{"facility":131,"status":42,"city":132,"state":133,"zip":134,"country":46,"countryCode":47,"cosmosGeoPoint":135,"geoPoint":139,"contacts":140},"Hunan Cancer Hospital","Changsha","Hunan","410013",{"type":49,"coordinates":136},[137,138],112.97087,28.19874,{"lat":138,"lon":137},[141],{"name":104,"role":36,"phone":27,"phoneExt":27,"email":27},{"facility":143,"status":42,"city":144,"state":145,"zip":146,"country":46,"countryCode":47,"cosmosGeoPoint":147,"geoPoint":151,"contacts":152},"The First People's Hospital of Changzhou","Changzhou","Jiangsu","213003",{"type":49,"coordinates":148},[149,150],119.95401,31.77359,{"lat":150,"lon":149},[153],{"name":154,"role":36,"phone":27,"phoneExt":27,"email":27},"Gu",{"facility":156,"status":42,"city":157,"state":145,"zip":158,"country":46,"countryCode":47,"cosmosGeoPoint":159,"geoPoint":163,"contacts":164},"Affiliated Hospital of Nantong University","Nantong","226001",{"type":49,"coordinates":160},[161,162],120.87472,32.03028,{"lat":162,"lon":161},[165],{"name":166,"role":36,"phone":27,"phoneExt":27,"email":27},"Shi",{"facility":168,"status":42,"city":169,"state":170,"zip":171,"country":46,"countryCode":47,"cosmosGeoPoint":172,"geoPoint":176,"contacts":177},"The First Affiliated Hospital of Nanchang University","Nanchang","Jiangxi","330006",{"type":49,"coordinates":173},[174,175],115.85306,28.68396,{"lat":175,"lon":174},[178],{"name":82,"role":36,"phone":27,"phoneExt":27,"email":27},{"facility":180,"status":42,"city":181,"state":182,"zip":183,"country":46,"countryCode":47,"cosmosGeoPoint":184,"geoPoint":188,"contacts":189},"The First Bethune Hospital of Jilin University","Changchun","Jilin","130021",{"type":49,"coordinates":185},[186,187],125.32278,43.88,{"lat":187,"lon":186},[190],{"name":191,"role":36,"phone":27,"phoneExt":27,"email":27},"Bai",{"facility":193,"status":194,"city":195,"state":196,"zip":197,"country":46,"countryCode":47,"cosmosGeoPoint":198,"geoPoint":202,"contacts":203},"Shengjing Hospital of China Medical University","NOT_YET_RECRUITING","Shenyang","Liaoning","110004",{"type":49,"coordinates":199},[200,201],123.43278,41.79222,{"lat":201,"lon":200},[204],{"name":205,"role":36,"phone":27,"phoneExt":27,"email":27},"Yang",{"facility":207,"status":42,"city":208,"state":209,"zip":210,"country":46,"countryCode":47,"cosmosGeoPoint":211,"geoPoint":215,"contacts":216},"West China Hospital of Sichuan University","Chengdu","Sichuan","610041",{"type":49,"coordinates":212},[213,214],104.06667,30.66667,{"lat":214,"lon":213},[217],{"name":30,"role":36,"phone":27,"phoneExt":27,"email":27},{"facility":219,"status":42,"city":220,"state":221,"zip":222,"country":46,"countryCode":47,"cosmosGeoPoint":223,"geoPoint":227,"contacts":228},"The First Affiliated Hospital, Zhejiang University School of Medicine","Hangzhou","Zhejiang","310003",{"type":49,"coordinates":224},[225,226],120.16142,30.29365,{"lat":226,"lon":225},[229],{"name":230,"role":36,"phone":27,"phoneExt":27,"email":27},"Yu",{"type":232,"investigatorFullName":27,"investigatorTitle":27,"investigatorAffiliation":27,"oldNameTitle":27,"oldOrganization":27},"SPONSOR","100604803","phase-2-a-study-of-dzd8586-combination-in-cllsll-tai-shan10-100604803",false,"NCT07154264","A Study of DZD8586 Combination in CLL\u002FSLL (TAI-SHAN10)","A Phase 2 Study of DZD8586 Combination Therapy in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL\u002FSLL)","Inclusion Criteria:\n\n1. Male and female ≥ 18 years of age.\n2. ECOG performance status 0-2, and life expectancy ≥ 6 months.\n3. Confirmed newly diagnosis or treatment naïve CLL\u002FSLL with indication for treatment.\n4. Patients with SLL must have at least one measurable lesion.\n5. Adequate bone marrow reserve and organ functions.\n6. Willing to comply with contraceptive restrictions.\n\nExclusion Criteria:\n\n1. Any of previous or current treatment prohibited by protocol.\n2. Any unresolved \\> grade 1 drug-related adverse events.\n3. Known or suspected Richter's transformation, or prolymphocytic leukemia.\n4. CNS involvement.\n5. Active infection.\n6. Any of severe cardiac or pulmonary abnormalities.\n7. Poorly controlled autoimmune anemia or autoimmune thrombocytopenia.\n8. Poorly controlled gastrointestinal disorder, inadequate absorption of medication or other systemic diseases.\n9. Prior malignancy within the past 3 years.\n10. Known allergy to study drugs, any of the ingredients of the study drugs, or xanthine oxidase inhibitors or rasburicase.","ALL","18 Years",{"count":243,"type":244},66,"ESTIMATED","INTERVENTIONAL",[247],"PHASE2","This is a phase 2 study to investigate the efficacy and safety of DZD8586 in combination in participants with CLL\u002FSLL.\n\nThis study consists of two parts: Part A is the safety lead-in phase, and Part B is the dose expansion phase.",[250],"Chronic Lymphocytic Leukemia\u002FSmall Lymphocytic Lymphoma","2026-06-18",{"date":253,"type":254},"2026-06-22","ACTUAL",{"date":256,"type":254},"2025-09-22",{"date":258,"type":244},"2030-01",{"name":5,"class":6},15]